We are live on ! Find out more
ELAN icon

Elanco Animal Health

418 hedge funds and large institutions have $5.9B invested in Elanco Animal Health in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 160 increasing their positions, 144 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $110M | Put options by funds: $27.5M

11% more repeat investments, than reductions

Existing positions increased: 160 | Existing positions reduced: 144

1% more ownership

Funds ownership: 99.28%100.28% (+1%)

5% less funds holding

Funds holding: 438418 (-20)

22% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 81

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

36% less capital invested

Capital invested by funds: $9.18B → $5.9B (-$3.28B)

Holders
418
Holders Change
-20
Holders Change %
-4.57%
% of All Funds
7.2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
63
Increased
160
Reduced
144
Closed
81
Calls
$110M
Puts
$27.5M
Net Calls
+$82.2M
Net Calls Change
+$85.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
251
Osaic Holdings
Arizona
$373K -$1.43M -81,990 -73%
LW
252
Linscomb Wealth
Texas
$367K +$41.2K +2,358 +9%
Commonwealth Equity Services
253
Commonwealth Equity Services
Massachusetts
$363K -$63K -3,607 -11%
MC
254
Moors & Cabot
Massachusetts
$363K -$27K -1,542 -5%
Nisa Investment Advisors
255
Nisa Investment Advisors
Missouri
$363K +$40.8K +2,335 +9%
SSWM
256
Smith Salley Wealth Management
North Carolina
$357K +$38.4K +2,194 +8%
Creative Planning
257
Creative Planning
Kansas
$352K +$62.8K +3,592 +14%
KA
258
Keene & Associates
Texas
$345K +$39.4K +2,255 +9%
Nordea Investment Management
259
Nordea Investment Management
Sweden
$341K +$44.5K +2,548 +10%
XT
260
XTX Topco
Cayman Islands
$330K +$282K +16,138 +154%
PI
261
PEAK6 Investments
Illinois
$326K -$513K -29,357 -53%
EI
262
Ethic Inc
New York
$325K +$194K +11,088 +73%
VF
263
Virtu Financial
New York
$313K -$1.19M -67,963 -73%
TNA
264
True North Advisors
Texas
$310K +$437K +25,000 New
BC
265
Bridgefront Capital
Texas
$306K -$9.61K -550 -2%
FRM
266
Fox Run Management
Connecticut
$298K +$420K +24,021 New
MMA
267
Miracle Mile Advisors
California
$296K +$416K +23,820 New
CIBC Asset Management
268
CIBC Asset Management
Ontario, Canada
$289K +$1.08K +62 +0.3%
NFGCM
269
Norman Fields Gottscho Capital Management
New York
$284K -$79.8K -4,565 -17%
QT
270
Quantamental Technologies
New York
$277K +$390K +22,340 New
SMDAM
271
Sumitomo Mitsui DS Asset Management
Japan
$275K +$4.68K +268 +1%
AII
272
AGF Investments Inc
Ontario, Canada
$274K -$5.35M -306,036 -93%
ET
273
Equitable Trust
Tennessee
$271K +$12.7K +727 +3%
GWM
274
Geneos Wealth Management
Colorado
$262K +$143K +8,173 +63%
NIMI
275
Natixis Investment Managers International
France
$256K -$911K -52,100 -72%

ELAN Hedge Fund Activity: Q3 2022 in Review

418 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2022, worth a combined $5.9B — down 36% from $9.18B a quarter earlier.

Sellers outnumbered buyers: 81 funds closed out of ELAN and 63 opened new positions — a net loss of 18 holders — while 144 trimmed existing stakes and 160 added.

The largest buyer was Janus Henderson Group, adding an estimated $212M. The largest seller was Aristotle Capital Management, cutting an estimated $411M.

  • 418 institutional investors held Elanco Animal Health (ELAN) as of Q3 2022, down from 438 in Q2 2022.
  • Funds reported $5.9B of Elanco Animal Health stock for Q3 2022, down 36% quarter-over-quarter.
  • 63 funds opened new Elanco Animal Health positions in Q3 2022 and 81 closed out, a net change of -18 holders.
  • The largest Elanco Animal Health buyer in Q3 2022 was Janus Henderson Group, an estimated $212M added.
  • The largest Elanco Animal Health seller in Q3 2022 was Aristotle Capital Management, an estimated $411M sold.

Based on aggregated 13F filings for Q3 2022.